SULFUR-CONTAINING EXCITATORY AMINO ACID-EVOKED CA2+-INDEPENDENT RELEASE OF D-[3H]ASPARTATE FROM CULTURED CEREBELLAR GRANULE CELLS - THE ROLE OF GLUTAMATE RECEPTOR ACTIVATION COUPLED TO REVERSAL OF THE ACIDIC AMINO-ACID PLASMA-MEMBRANE CARRIER

被引:25
作者
DUNLOP, J
GRIEVE, A
DAMGAARD, I
SCHOUSBOE, A
GRIFFITHS, R
机构
[1] UNIV ST ANDREWS,DEPT BIOCHEM & MICROBIOL,ST ANDREWS KY16 9AL,FIFE,SCOTLAND
[2] ROYAL DANISH SCH PHARM,DEPT BIOL SCI,PHARMABIOTEC RES CTR,DK-2100 COPENHAGEN,DENMARK
关键词
D O I
10.1016/0306-4522(92)90385-F
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Sulphur-containing excitatory amino acid transmitter candidates (500-mu-M) stimulated the Ca2+-independent efflux of exogenously-supplied D-[H-3]aspartate from primary cultures of cerebellar granule cells superfused continuously with HEPES-buffered saline containing CoCl2 (1 MM) in place of CaCl2. The stimulated release of D-[H-3]aspartate was markedly attenuated by 200-mu-M 6,7-dinitroquinoxalinedione, a concentration at which the antagonist inhibits both non-N-methyl-D-aspartate and N-methyl-D-aspartate ionotropic excitatory amino acid receptors. The Ca2+-independent component of evoked release was also markedly attenuated and, in some cases, abolished by removing NaCl from the superfusion medium. Furthermore, when 700-mu-M dihydrokainate (demonstrated herein as a mixed/non-competitive inhibitor of the high-affinity dicarboxylic amino acid transporter in cultured granule cells) was included in the superfusion medium, stimulated efflux of D-[H-3]aspartate was reduced by between 15-78% of the control response; the extent of inhibition varying with the agonist employed. In contrast, agents which act as competitive inhibitors of the plasma membrane carrier in granule cells, e.g. beta-methylene-D,L-aspartate, potentiated the release of D-[H-3]aspartate in a synergistic manner. Taken together, these findings are consistent with a mechanism for the Ca2+-independent release of D-[H-3]aspartate that is mediated predominantly by activation of excitatory amino acid receptors resulting in a reversal of the high-affinity dicarboxylic amino acid transport system. Although the physiological relevance of such non-vesicular release from the cytosol remains obscure and is still a matter of some debate, this mode of release may be of pathological significance.
引用
收藏
页码:107 / 115
页数:9
相关论文
共 57 条
[1]   EXTRACELLULAR ACIDIC SULFUR-CONTAINING AMINO-ACIDS AND GAMMA-GLUTAMYL PEPTIDES IN GLOBAL-ISCHEMIA - POSTISCHEMIC RECOVERY OF NEURONAL-ACTIVITY IS PARALLELED BY A TETRODOTOXIN-SENSITIVE INCREASE IN CYSTEINE SULFINATE IN THE CA1 OF THE RAT HIPPOCAMPUS [J].
ANDINE, P ;
ORWAR, O ;
JACOBSON, I ;
SANDBERG, M ;
HAGBERG, H .
JOURNAL OF NEUROCHEMISTRY, 1991, 57 (01) :230-236
[2]  
BARLOW RB, 1983, BIODATA HANDLING MIC
[3]  
BENDER AS, 1989, NEUROCHEM RES, V14, P641
[4]   KYNURENATE AND FG9041 HAVE BOTH COMPETITIVE AND NON-COMPETITIVE ANTAGONIST ACTIONS AT EXCITATORY AMINO-ACID RECEPTORS [J].
BIRCH, PJ ;
GROSSMAN, CJ ;
HAYES, AG .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 151 (02) :313-315
[5]   CEREBRAL METABOLIC AND CIRCULATORY CHANGES IN THE RAT DURING SUSTAINED SEIZURES INDUCED BY DL-HOMOCYSTEINE [J].
BLENNOW, G ;
FOLBERGROVA, J ;
NILSSON, B ;
SIESJO, BK .
BRAIN RESEARCH, 1979, 179 (01) :129-146
[6]   CONFORMATIONALLY DEFINED NEUROTRANSMITTER ANALOGS - SELECTIVE-INHIBITION OF GLUTAMATE UPTAKE BY ONE PYRROLIDINE-2,4-DICARBOXYLATE DIASTEREOMER [J].
BRIDGES, RJ ;
STANLEY, MS ;
ANDERSON, MW ;
COTMAN, CW ;
CHAMBERLIN, AR .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (02) :717-725
[7]   HOMOCYSTEINE-INDUCED ALTERATIONS IN EXTRACELLULAR AMINO-ACIDS IN RAT HIPPOCAMPUS [J].
BUTCHER, SP ;
CAMERON, D ;
KENDALL, L ;
GRIFFITHS, R .
NEUROCHEMISTRY INTERNATIONAL, 1992, 20 (01) :75-80
[8]   INFLUENCE OF THE MALATE-ASPARTATE SHUTTLE ON OXIDATIVE-METABOLISM IN SYNAPTOSOMES [J].
CHEESEMAN, AJ ;
CLARK, JB .
JOURNAL OF NEUROCHEMISTRY, 1988, 50 (05) :1559-1565
[9]   INHIBITION OF GLUTAMATE-ASPARTATE TRANSAMINASE BY BETA-METHYLENE-DL-ASPARTATE [J].
COOPER, AJL ;
FITZPATRICK, SM ;
GINOS, JZ ;
KAUFMAN, C ;
DOWD, P .
BIOCHEMICAL PHARMACOLOGY, 1983, 32 (04) :679-689
[10]  
CURTIS DR, 1963, J PHYSIOL-LONDON, V166, P1